Workflow
Axogen, Inc. Reports Third Quarter 2025 Financial Results
AxoGenAxoGen(US:AXGN) Globenewswire·2025-10-29 19:00

Raises Full Year Revenue Guidance to at Least 19% Growth or 222.8millionALACHUA,Fla.andTAMPA,Fla.,Oct.29,2025(GLOBENEWSWIRE)−−Axogen,Inc.(NASDAQ:AXGN),agloballeaderindevelopingandmarketinginnovativesurgicalsolutionsfortherestorationofperipheralnervefunction,todayreportedfinancialresultsandbusinesshighlightsforthethirdquarterendedSeptember30,2025.ThirdQuarterFinancialResultsThirdquarterrevenuewas222.8 millionALACHUA, Fla. and TAMPA, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial results and business highlights for the third quarter ended September 30, 2025. Third Quarter Financial Results Third quarter revenue was 60.1 million, a 23.5% increase compared to the third qua ...